Sage Journals: Discover world-class research

Retricted access

Research article

First published 2024-12

Polypharmacy and drug-drug interactions in metastatic breast cancer patients receiving cyclin-dependent kinase (CDK) 4/6 inhibitors

Tanju Kapagan, Nilufer Bulut, Gokmen Umut Erdem

Journal of Oncology Pharmacy Practice

Retricted access

Case report

First published 2020-12

Interaction Between Cyclosporine and Palbociclib in a Renal Transplant Patient: Case Report and Pharmacokinetic Perspective

Jeremiah D. Momper, Jin Yang, Janice Kerr [...]

Journal of Pharmacy Practice

Retricted access

Research article

First published 2025-10

Proton pump inhibitors decrease efficacy of palbociclib in patients with metastatic breast

Javier Álvarez Criado, Pilar Zamora Auñon, Virginia Martínez Marín [...]

Journal of Oncology Pharmacy Practice

Retricted access

Case report

First published 2019-4

Verapamil as a culprit of palbociclib toxicity

Jasmine L Gowarty, Jon D Herrington

Journal of Oncology Pharmacy Practice

Open access

Review article

First published 2019

Palbociclib and ribociclib in breast cancer: consensus workshop on the management of concomitant medication

Meritxell Bellet, Faten Ahmad, Rafael Villanueva [...]

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2018

Updates on managing advanced breast cancer with palbociclib combination therapy

Teresa M. McShane, Thomas A. Wolfe, Joanne C. Ryan

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2025

A single-centre retrospective evaluation of potential drug-drug interactions in breast cancer patients undergoing CDK 4/6 inhibitors chemotherapy

Prajakta Harish Patil, Mrunal Pradeep Desai, Gayathri Baburaj [...]

Journal of Oncology Pharmacy Practice

Retricted access

Case report

First published 2025-10

Ribociclib-Induced hepatotoxicity exacerbated by fenugreek supplement use: A case report

Yousra Al Harrak, Sihame Lkhoyaali, Oumaima Lamsyah [...]

Journal of Oncology Pharmacy Practice

Retricted access

Review article

First published 2019-2

Review of Cyclin-Dependent Kinase 4/6 Inhibitors for the Treatment of Hormone Receptor–Positive Advanced Breast Cancer

Keith A. Hecht, Christopher Selby

Annals of Pharmacotherapy

Open access

Research article

First published 2026

The administration of proton pump inhibitors with the CDK4/6 inhibitor abemaciclib does not affect the clinical outcome of metastatic breast cancer patients

Stefania Crucitta, Paola Cinacchi, Irene Bargagna [...]

Therapeutic Advances in Drug Safety

Search results